Patent · US Active

Collagen hydrolysate and use thereof

US10364283B2 · kind B2 · utility

2Cited by

4References

13Claims

0Family size

Assignee

GELITA AG · DE

Inventors

Steffen Oesser · Glücksburg, DE
Monika Giesen-Wiese · Bad König, DE
Hans-Ulrich Frech · Weinheim, DE
Stephan Hausmanns · Heidelberg, DE

Key dates

Filing date	Apr 28, 2015
Grant date	Jul 30, 2019
Priority date	—
Expiry date	Feb 1, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA23V2002/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a collagen hydrolysate which is produced by enzymatic hydrolysis of type-B bone gelatin, wherein the collagen hydrolysate is formed from peptides of which at least 50% by weight, in particular at least 70% by weight have a molecular weight of 1,500 Da to 3,500 Da, and which have a mean molecular weight in the range from 4,000 Da to 8,000 Da, in particular in the range from 4,500 Da to 6,000 Da. The invention also relates to the use of this collagen hydrolysate as an active ingredient to maintain and/or improve the health of the bones, in particular to prevent and/or treat osteoporosis. The invention further relates to a nutritional supplement which comprises the collagen hydrolysate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.